搜索此博客

2019年7月1日星期一

CAS 1256377-67-9;1044040-56-3(free) ,FamitinibMalate World Biggest Manufacturer

FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) World Biggest Manufacturer

FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) stable novel crystalline or amorphous form both we have, FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free)no any IP problem. FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) DMF filling, free sample of FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free).

EOS Med Chem have already carried out FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) Intermeidates list, most from GMP plant:

"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  107044-80-4, stock 6.5kg, assay 98.7%, White powder."
"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  945381-56-6, stock 3.4kg, assay 98.5%, White powder."
"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  945381-57-7, stock 5.3kg, assay 98.9%, White powder."
"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  945381-58-8, stock 4kg, assay 98.6%, White powder."
"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  945381-59-9, stock 5.4kg, assay 98.1%, White powder."
"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  945381-60-2, stock 9.7kg, assay 98.2%, White powder."
"FamitinibMalate, CAS 1256377-67-9;
1044040-56-3(free) Intermediate,  945381-61-3, stock 9.7kg, assay 98.1%, White powder."


FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free) HNMR, MASS, COA, MSDS we have.

FamitinibMalate, CAS 1256377-67-9;1044040-56-3(free), free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com